The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse

Philip R Taylor1, Matthew C Pickering, Marie H Kosco-Vilbois

  • 1Sir William Dunn School of Pathology, Oxford University, South Parks Road, Oxford, GB.

Insights

The follicular dendritic cell marker FDC-M2 is identified as complement component C4. This finding reveals new insights into immune complex clearance and complement deposition in inflammatory diseases.

Area of Science:

  • Immunology
  • Complement System Biology

Background:

  • Follicular dendritic cells (FDCs) are crucial for adaptive immunity.
  • The FDC-M2 marker, recognized by mAb209, has been used to study FDCs.
  • The precise identity and function of FDC-M2 have remained unclear.

Purpose of the Study:

  • To identify the molecular nature of the murine FDC marker FDC-M2.
  • To investigate the role of FDC-M2 in immune complex-mediated inflammation and clearance.
  • To evaluate mAb209 as a tool for studying complement deposition in vivo.

Main Methods:

  • Immunohistochemistry using mAb209 on wild-type and complement-deficient mice.
  • Analysis of FDC-M2 distribution in various tissues, particularly at sites of inflammation.
  • Comparison of immune complex deposition and clearance in different complement-deficient models.

Main Results:

  • The FDC-M2 marker was identified as complement component C4.
  • FDC-M2 (C4) was detected at sites of immune complex-mediated inflammation.
  • Distinct populations of FDC-M2+ cells in the spleen, separate from FDCs, were involved in immune complex capture.

Conclusions:

  • Monoclonal antibody mAb209 recognizes complement component C4, not solely an FDC-specific protein.
  • mAb209 is a valuable tool for analyzing complement deposition and immune complex dynamics in vivo.
  • The study reveals novel roles for FDC-M2+ cells in immune complex handling beyond traditional FDCs.

Related Concept Videos